A material substance originating from a biological entity intended to be transplanted or infused into another (possibly the same) biological entity.

Substances include, but are not limited to: whole blood, bone marrow, organs, and manipulated blood cells.

This records identifiers associated with this biologically derived product instance that are defined by business processes and/or used to refer to it when a direct URL reference to the resource itself is not appropriate (e.g. in CDA documents, or in written / printed documentation).

Broad category of this product.

A code that identifies the kind of this biologically derived product (SNOMED Ctcode).

Whether the product is currently available.

Procedure request to obtain this biologically derived product.

Number of discrete units within this product.

Parent product (if any).

For products that have multiple collections. For example Peripheral Blood Stem Cells may be collected over several days from a single donor and the donation split into in multiple containers which must be linked to the parent donation.

How this product was collected.

Healthcare professional who is performing the collection.

The patient or entity, such as a hospital or vendor in the case of a processed/manipulated/manufactured product, providing the product.

Time of product collection.

Any processing of the product during collection that does not change the fundamental nature of the product. For example adding anti-coagulants during the collection of Peripheral Blood Stem Cells.

Description of of processing.

Procesing code.

Substance added during processing.

Time of processing.

Any manipulation of product post-collection that is intended to alter the product. For example a buffy-coat enrichment or CD8 reduction of Peripheral Blood Stem Cells to make it more suitable for infusion.

Description of manipulation.

Time of manipulation.

Product storage.

Description of storage.

Storage temperature.

Temperature scale used.

Storage timeperiod.